S100A9 and atherosclerosis: Kraakman et al.76have reported that the inhibition of S100A9 can reduce the formation of atherosclerosis in diabetic mice; in diabetic patients, inhibition of S100A9 bioactivity suppresses platelet production, which may help to reduce the incidence and severity of cardiovascular events.